首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1695958篇
  免费   125985篇
  国内免费   3699篇
耳鼻咽喉   21819篇
儿科学   55857篇
妇产科学   46414篇
基础医学   241457篇
口腔科学   48986篇
临床医学   151074篇
内科学   332144篇
皮肤病学   38752篇
神经病学   131425篇
特种医学   64201篇
外国民族医学   244篇
外科学   258839篇
综合类   39204篇
一般理论   548篇
预防医学   124647篇
眼科学   40206篇
药学   123996篇
  7篇
中国医学   4357篇
肿瘤学   101465篇
  2019年   13554篇
  2018年   19935篇
  2017年   15297篇
  2016年   16663篇
  2015年   19048篇
  2014年   26564篇
  2013年   38492篇
  2012年   53524篇
  2011年   56220篇
  2010年   33154篇
  2009年   31035篇
  2008年   52179篇
  2007年   55471篇
  2006年   55905篇
  2005年   53156篇
  2004年   51333篇
  2003年   48672篇
  2002年   46810篇
  2001年   92021篇
  2000年   93799篇
  1999年   76916篇
  1998年   18927篇
  1997年   16409篇
  1996年   16542篇
  1995年   16766篇
  1994年   15356篇
  1993年   14095篇
  1992年   57596篇
  1991年   55520篇
  1990年   53198篇
  1989年   50974篇
  1988年   46352篇
  1987年   45141篇
  1986年   42432篇
  1985年   40223篇
  1984年   29509篇
  1983年   24991篇
  1982年   13983篇
  1981年   12434篇
  1979年   25625篇
  1978年   17667篇
  1977年   14953篇
  1976年   13915篇
  1975年   14585篇
  1974年   17685篇
  1973年   17011篇
  1972年   15750篇
  1971年   14523篇
  1970年   13491篇
  1969年   12575篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Clinical Rheumatology - To examine the mortality rates and causes of death among French decedents with Behçet’s disease (BD). Data collected between 1979 and 2016 by the French...  相似文献   
2.
Coates  Laura C.  Mease  Philip  Kronbergs  Andris  Helt  Cameron  Sandoval  David  Park  So Young  Combe  Bernard  Nash  Peter  Deodhar  Atul 《Clinical rheumatology》2022,41(10):3035-3047
Clinical Rheumatology - To evaluate the three-year efficacy and safety of ixekizumab with and without concomitant conventional synthetic disease-modifying antirheumatic drug (csDMARD) use in...  相似文献   
3.
The International Journal of Cardiovascular Imaging - Global longitudinal strain (GLS) has proven to be a powerful prognostic marker in various patient populations, but the prognostic value of...  相似文献   
4.

Fears regarding various aspects tend to stimulate individuals to escape or to avoid the sources of the threat. We concluded that fears associated with the future aging process, like the fear of aging-related diseases, the fear of loneliness in old age, and the fear of death, would stimulate patterns of avoidance when it comes to ideal life expectancy. We expected fear of aging-related diseases and fear of loneliness in old age to be related to lower ideal life expectancies. We expected fear of death to be related to higher ideal life expectancies. In two adult lifespan samples [N1?=?1065 and N2?=?591; ages ranging from 18 to 95 years, M (SD)1?=?58.1 (17.2) years, M (SD)2?=?52.6 (18.1) years], we were able to support our hypothesis regarding fear of death. We furthermore found significant interactions among the fears, indicating that individuals fearing diseases or loneliness but being unafraid of death opted for the shortest lives. Our results indicate that fears regarding life in very old age might be associated with the wish to avoid this age period; the fear of death was however associated with the wish for particularly long lives, and thus, with distancing oneself from the dreaded event of death. We conclude that fears seem to be associated with how individuals approach old age and with what they wish for in their own future as aged people.

  相似文献   
5.
6.
7.
8.
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single-institution, prospective, nonrandomized study. Patients in active treatment and a control cohort of healthy people received two doses of BNT162b2 (Comirnaty, BioNTech/Pfizer, The United States) or mRNA-1273 (Spikevax, Moderna). Vaccine was administered before starting anticancer therapy or on the first day of the treatment cycle. SARS-CoV-2 antibody levels against S1, RBD (to evaluate vaccine response) and N proteins (to evaluate previous infection) were measured in plasma before the first dose and 30 days after the second one. From January to June 2021, 195 consecutive cancer patients and 20 healthy controls were enrolled. Thirty-one cancer patients had a previous exposure to SARS-CoV-2. Cancer patients previously exposed to the virus had significantly higher median levels of anti-S1 and anti-RBD IgG, compared to healthy controls (P = .0349) and to cancer patients without a previous infection (P < .001). Vaccine type (anti-S1: P < .0001; anti-RBD: P = .0045), comorbidities (anti-S1: P = .0274; anti-RBD: P = .0048) and the use of G-CSF (anti-S1: P = .0151) negatively affected the antibody response. Conversely, previous exposure to SARS-CoV-2 significantly enhanced the response to vaccination (anti-S1: P < .0001; anti-RBD: P = .0026). Vaccine immunogenicity in cancer patients with a previous exposure to SARS-CoV-2 seems comparable to that of healthy subjects. On the other hand, clinical variables of immune frailty negatively affect humoral immune response to vaccination.  相似文献   
9.
10.
European Child & Adolescent Psychiatry - Substance abuse is a significant public health concern that disproportionately burdens males and low-income communities. This study examined (1)...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号